Cyteir Therapeutics Inc
NASDAQ:CYT 3:59:50 PM EDT
Earnings Announcements
Cyteir Therapeutics Reports First Quarter 2022 Financial Results
Published: 05/05/2022 20:39 GMT
Cyteir Therapeutics Inc (CYT) - Cyteir Therapeutics Reports First Quarter 2022 Financial Results and Operational Highlights.
Q1 Loss per Share $0.40.
Q1 Earnings per Share View $-0.39 -- Refinitiv Ibes Data (analyst estimates).
Q1 Loss per Share $0.40.
Q1 Earnings per Share View $-0.39 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.44
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.46
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.44
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.46
More details on our Analysts Page.